NPI: 1801261029 · MUNFORDVILLE, KY 42765 · Family Medicine Physician · NPI assigned 12/14/2015
Authorized official LAWLESS, MICHELE controls 20+ related entities in our dataset. Read more
| Authorized Official | LAWLESS, MICHELE (EXECUTIVE VICE PRESIDENT/CFO) |
| NPI Enumeration Date | 12/14/2015 |
Other providers sharing the same authorized official: LAWLESS, MICHELE
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 4,482 | $140K |
| 2019 | 5,749 | $189K |
| 2020 | 5,893 | $165K |
| 2021 | 10,551 | $145K |
| 2022 | 21,043 | $137K |
| 2023 | 16,401 | $133K |
| 2024 | 11,313 | $114K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 14,792 | 11,805 | $459K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 9,401 | 7,415 | $425K |
| 80305 | 2,592 | 1,666 | $25K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1,410 | 992 | $20K |
| 99490 | Ccm add 20min | 832 | 782 | $19K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 235 | 212 | $18K |
| 99439 | 454 | 420 | $15K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 86 | 81 | $10K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 86 | 82 | $8K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 122 | 111 | $5K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 141 | 130 | $5K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 63 | 60 | $3K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 178 | 164 | $2K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 28 | 27 | $2K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 27 | 26 | $2K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 127 | 113 | $2K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 67 | 56 | $2K |
| 99215 | Prolong outpt/office vis | 19 | 17 | $1K |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 300 | 252 | $1K |
| 99308 | Subsequent nursing facility care, per day, straightforward | 18 | 13 | $810.60 |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | 22 | 12 | $763.61 |
| G0444 | Annual depression screening, 5 to 15 minutes | 332 | 306 | $277.07 |
| 81025 | 44 | 36 | $232.46 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 13 | 13 | $157.98 |
| 99406 | 13 | 13 | $82.23 | |
| 81003 | 56 | 50 | $33.45 | |
| 3008F | 7,336 | 5,989 | $12.83 | |
| 3078F | 4,965 | 4,167 | $11.19 | |
| 3074F | 4,188 | 3,559 | $9.27 | |
| 1125F | 2,862 | 2,441 | $7.77 | |
| 3077F | 2,686 | 2,282 | $7.72 | |
| 3075F | 2,115 | 1,888 | $5.60 | |
| 3079F | 2,139 | 1,912 | $5.57 | |
| 3080F | 1,686 | 1,470 | $5.25 | |
| 1126F | 1,959 | 1,695 | $5.07 | |
| 1159F | 3,800 | 3,172 | $3.69 | |
| 1160F | 2,502 | 2,112 | $3.51 | |
| 1034F | 3,920 | 3,158 | $1.83 | |
| 1036F | 3,034 | 2,515 | $1.68 | |
| 1170F | 272 | 252 | $0.97 | |
| 1124F | 265 | 244 | $0.18 | |
| 3288F | 151 | 136 | $0.17 | |
| 3044F | 13 | 13 | $0.05 | |
| 0518F | 13 | 13 | $0.03 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 68 | 65 | $0.00 |